Abstract

This study is aimed at determining the ability of computed tomography- (CT-) based radiomic analysis to distinguish between grade 0/1 and grade 2/3 macrovesicular steatosis (MaS) in cadaveric donor liver transplantation cases. Preoperative noncontrast-enhanced CT images of 150 patients with biopsy-confirmed MaS were analyzed retrospectively; these patients were classified into the low-grade MaS (n = 100, grade 0 or 1) and high-grade MaS (n = 50, grade 2 or 3) groups. Three-dimensional spherical regions of interest of 40 pixel (2.5 cm) in diameter were placed in the right anterior and left lateral segments of the liver. Thereafter, 300 regions of interest (ROIs) were segmented and randomly assigned to the training and testing groups at a ratio of 7 : 3. A total of 402 radiomic features were extracted from each ROI. For MaS classification, a radiomic model was established using multivariate logistic regression analysis. Clinical data, including age, sex, and liver function, were collected to establish the clinical model at the patient level. The performances of the radiomic and clinical models, i.e., the diagnostic discrimination, calibration, and clinical utilities, were evaluated. The radiomic model, with seven selected features, depicted a good discrimination with an area under the receiver operating characteristic curve (AUC) of 0.907 (95% confidence interval (CI): 0.869–0.940) in the training cohort and 0.906 (95% CI: 0.843–0.959) in the testing cohort. The calibration curve revealed good agreement between the predicted and observed probabilities in the training and testing cohorts (both P > 0.05 in the H-L test). Decision curve analysis revealed that the radiomic model was more beneficial than the treat-all or treat-none schemes for predicting the MaS grade. Alanine transaminase and gamma-glutamyl transferase were used for building the clinical model, and the AUC was 0.784 in the total cohort. The CT-based radiomic model outperforming the conventional clinical model could provide an important reference for MaS grading in cadaveric liver donors.

Highlights

  • The insufficient number of grafts available for liver transplantation (LT) has increased mortality among patients on waiting lists and triggered the use of organs from marginal donors

  • The aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) levels were significantly higher in the high-grade MaS” (HGM) group than in the LGM group, with P values of 0.005,

  • We developed a radiomic signature based on noncontrast-enhanced CT (NECT) and the capability of this radiomic signature for estimating the macrovesicular steatosis (MaS) grade was found to be satisfactory

Read more

Summary

Introduction

The insufficient number of grafts available for liver transplantation (LT) has increased mortality among patients on waiting lists and triggered the use of organs from marginal donors. One of the most common marginal donors for LT are those with hepatic steatosis. Hepatic steatosis is considered one of the most common disorders; this is mostly due to the growing incidence of nonalcoholic fatty liver disease [1,2,3]. Available evidence reveals an increased risk of poor graft outcomes in patients with moderate-to-severe steatotic livers [2, 5]. We have focused on macrovesicular steatosis (MaS) in this study because it is a major cause of graft failure in donor livers [6]. Accurate grading of MaS is important in the evaluation of donors before LT

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call